Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) announced the appointment of Dr. Matthew A. Roberts as Public Safety and Defense Advisor, signaling a strategic expansion of its AI-powered chemical synthesis platform, Reactosphere, into public safety, biosecurity, health security, and defense-related applications. The move underscores the company's commitment to leveraging artificial intelligence for critical sectors beyond traditional drug discovery.
Dr. Roberts brings extensive experience in national security and defense, which will guide Redwood AI in positioning Reactosphere to address emerging threats in biosecurity and health security. The platform, which uses advanced AI to accelerate chemistry research and development, is designed to streamline the synthesis and scale-up of new compounds, potentially enabling faster responses to chemical and biological threats. For leaders in business and technology, this development highlights the growing convergence of AI and chemistry in solving high-stakes challenges, from pandemic preparedness to defense against chemical agents.
In conjunction with the appointment, Redwood AI also announced the extension of its market awareness and corporate communications engagement with MCS Market Communication Service GmbH through July 30, 2026, with a budget of CAD $900,000. This investment reflects the company's focus on increasing visibility among investors and stakeholders as it pursues new market opportunities.
The implications for the industry are significant. By targeting public safety and defense, Redwood AI is diversifying its application of Reactosphere beyond pharmaceutical R&D, potentially opening new revenue streams and partnerships with government agencies. For the broader technology and AI sectors, this move exemplifies how AI platforms can be adapted for dual-use applications—benefiting both commercial and national security interests. The appointment of a dedicated advisor also signals a structured approach to navigating regulatory and operational complexities in defense contracting.
About Redwood AI Corp., the company states it uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications. For more information about the company, please visit https://redwoodai.com/.
To view the full press release, visit https://ibn.fm/hiyD3.
